share_log

HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target

Benzinga Real-time News ·  Feb 7, 2023 06:21

HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment